Vanoxerine is primarily investigated for its potential therapeutic applications in treating neurological and psychiatric disorders. It functions as a dopamine reuptake inhibitor, making it a candidate for addressing conditions like cocaine addiction and Parkinson's disease. In addiction treatment, it helps reduce cravings and relapse by modulating dopamine levels in the brain. For Parkinson's, it may alleviate motor symptoms by enhancing dopaminergic activity. Additionally, vanoxerine has been explored for its antiarrhythmic properties, particularly in managing atrial fibrillation, due to its ability to block certain ion channels in the heart. Its dual action on the brain and heart makes it a versatile compound in medical research.